AN ACELLULAR RESUSCITATIVE FLUID

Award Information
Agency:
Department of Defense
Branch
Army
Amount:
$41,250.00
Award Year:
1987
Program:
SBIR
Phase:
Phase I
Contract:
n/a
Agency Tracking Number:
6117
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Microfoam Inc
9372 Elm St, Chadwicks, NY, 13319
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
LAWRENCE C CERNY
(315) 733-2217
Business Contact:
() -
Research Institution:
n/a
Abstract
DURING THE PAST SEVERAL YEARS, GREAT ADVANCES HAVE BEEN MADE TOWARD THE GOAL OF PRODUCING AN OXYGEN-CARRYING RESUSCITATIVE FLUID, COMMONLY CALLED ARTIFICIAL BLOOD SUBSTITUTE. FROM THE PRELIMINARY STUDIES IN THIS LABORATORY, IT APPEARS FEASIBLE TO SYNTHESIZE A SUITABLE SUBSTANCE IN FREEZE-DRIED FORM. THE ARTIFICIAL BLOOD PROPOSED IN THIS INVESTIGATION CAN BE PRODUCED FROM A STABLIZED TETRAMERIC HEMOGLOBIN AND A MODIFIED HYDROXYETHYL STARCH. THE COMPOUND IN THIS STUDY HAS THE FOLLOWING ADVANTAGES: 1) MADE FROM READILY AVAILABLE AND INEXPENSIVE MATERIALS; 2) THE COMPOSITION IS KNOWN AND CAN BE VARIED TO MEET SPECIFIC NEEDS; 3) BLOOD TYPING IS UNNCESSARY; 4) NO DANGER OF CONTRACTING HEPATITIS OR TRANSFUSION-TRANSMITTED DISEASES SUCH AS AIDS; 5) LARGE VOLUME USAGE IS PRACTICAL; 6) THE FREEZE-DRIED PRODUCT MAKES STORAGE EASY; 7) THE LONG SHELF-LIFE OF THE PRODUCT MAKES IT VIABLE FOR EXTENDED PERIODS OF TIME, UP TO FIVE YEARS.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government